Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Impella 5.5 shows promise in certain non-shock, high-risk cardiac surgery patients
New data out of the AATS Annual Meeting identified significant potential for a new treatment strategy.
First patient enrolled in massive heart failure trial
Data from BENEFIT-HF, a new randomized study of CVRx's implantable Barostim device, could open up access to many more heart failure patients.
TAVR or SAVR? Cardiologists and heart surgeons highlight the care that goes into each decision
When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.
Study: As fathers protect children, fatherhood protects dads
Becoming a father seems to make a man less likely to die young. What’s more, when a father passes away within the first five years of his child’s life, the cause is usually non-natural and thus preventable.
FDA details Class I catheter recall over safety risk
The FDA first shared a warning about this issue back in April. Now, the agency has shared a critical update.

Model in the Abiomed booth showing placement of the Impella 5.5 liters per minute catheter heart pump. This is used for patients who need more support than a conventional Impella CP can offer, but does not require level of supported from ECMO.

Impella 5.5 shows promise in certain non-shock, high-risk cardiac surgery patients

New data out of the AATS Annual Meeting identified significant potential for a new treatment strategy.

First patient enrolled in massive heart failure trial

Data from BENEFIT-HF, a new randomized study of CVRx's implantable Barostim device, could open up access to many more heart failure patients.

TAVR or SAVR? Cardiologists and heart surgeons highlight the care that goes into each decision

When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.

Study: As fathers protect children, fatherhood protects dads

Becoming a father seems to make a man less likely to die young. What’s more, when a father passes away within the first five years of his child’s life, the cause is usually non-natural and thus preventable.

Beacon Tip Centimeter Sizing Catheter FDA alert

FDA details Class I catheter recall over safety risk

The FDA first shared a warning about this issue back in April. Now, the agency has shared a critical update.

Kimberly Hatch, RT(R)(CT)(ARRT), technical director of 3D lab at Banner Health, explains the advances in advanced visualization software what is needed to build a comprehensive cardiac 3D imaging lab.

Advanced AI helps 3D imaging labs evolve with the times

“Technology grows and grows,” as one lab director explained. “Our job is to keep up with it and use it in the most efficient and effective way.”

New ways to predict TAVR outcomes for individual heart patients

As TAVR continues to gain popularity, researchers remain focused on discovering new ways to predict short- and long-term outcomes. One recent study, for example, explored the potential of AI-enabled imaging assessments. Another analysis focused on the CALLY index.

Stroke prevention devices for TAVR fail to make an impact

Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.